When a company is considering an offer the role of CEO and BOD must be separate. I say something is up, probably some kind of business amalgamation around ZOPTREX or MACRILEN or both?
Lol - 18 million traded and it can't bust a buck? guess why?
Then why hasn't Roche already purchased OXGN with their cookie jar money? If they really wanted this it could be done with their petty cash .... easy answer ....
I figured it would at least temporarily spike to $1.15 range then drop but this couldn't barely break a buck, yet millions have already traded. Shorters? Naw, just level headed folks getting out as fast as they can.
There's no way a stock that is trading out of compliance facing delisting and a reverse split can hold a gain. Especially when Management doesn't even hold quarterly conference calls any more and has showed indifference to share price and Investors in the past. I hope Longs took the opportunity to dump and salvage what little they have left. Buzzards swarming now.